Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep819 | Pituitary - Basic | ECE2017

Non-functioning pituitary adenomas: association between clinical-pathological and molecular parameters

Barrera-Martin Ana , Vazquez-Borrego Maria-Carmen , Rebollo-Roman Angel , Garcia-Jurado Pedro-Blas , Moreno-Moreno Paloma , Alhambra-Exposito Maria-Rosa , Toledano-Delgado Alvaro , Castano Justo-P , Galvez-Moreno Maria-Angeles , Luque Raul-M

Non-functioning pituitary-adenomas (NFPAs) represent the most common pituitary tumor-type. To date, there are not clinical, biochemical, anatomo-pathological, immuno-histochemical or molecular parameters useful to predict their remission. Therefore, the aim of this study was to evaluate the potential relationship between the clinical, biochemical and pathological characteristics of patients with NFPAs, the expression profile of these tumours and the clinical outcomes during th...

ea0049ep929 | Pituitary - Basic | ECE2017

Potential role of biguanides and statins in the treatment of pituitary adenomas

Vazquez-Borrego Mari C. , Fuentes-Fayos Antonio C , Ibanez-Costa Alejandro , Blanco-Acevedo Cristobal , Venegas-Moreno Eva , Galvez-Moreno Maria A , Soto-Moreno Alfonso , Castano Justo P. , Luque Raul M.

Pituitary adenomas (PA) comprise a commonly underestimated pathology in terms of incidence and associated morbimortality. To date, somatostatin and dopamine analogs represent the main medical treatment, but an appreciable subset of patients are resistant or poorly responsive to these drugs. Therefore, the search for new approaches to control tumor growth and/or hormone secretion is crucial. Biguanides such as metformin (MF; commonly used to treat type-2 diabetes), phenformin (...

ea0044p157 | Neuroendocrinology and pituitary | SFEBES2016

Use of biguanides in the treatment of pituitary adenomas, an in vitro approach

Ibanez-Costa Alejandro , Carmen Vazquez-Borrego Ma , Fuentes-Fayos Antonio C. , Venegas-Moreno Eva , Galvez Ma Angeles , Soto-Moreno Alfonso , Kineman Rhonda D. , Castano Justo P. , Luque Raul M.

Pituitary adenomas (PA) comprise a commonly underestimated pathology in terms of incidence and associated morbi-mortality. Although somatostatin analogs and dopamine antagonists constitute the main medical treatments for PAs, an appreciable subset of patients are resistant or poorly responsive to these drugs and hence is crucial the search for new therapies. Biguanides such as metformin (MF; commonly used to treat type-2 diabetes), phenformin (PF) and buformin (BF) have been s...

ea0041oc3.1 | Diabetes prediction & complications | ECE2016

Identification of a spliceosome-associated fingerprint with potential to predict development of type 2 diabetes in high-risk patients

Luque Raul M. , Gahete Manuel D. , Rio-Moreno Mercedes del , Pedraza-Arevalo Sergio , Camargo Antonio , Delgado-Lista Javier , Gracia-Navarro Francisco , Perez-Jimenez Francisco , Lopez-Miranda Jose , Castano Justo P.

Prevalence of metabolic syndrome (MetS) and type-2 Diabetes (T2D) is growing dramatically worldwide. Loss of phenotypic flexibility, i.e. the difficulty to cope with different stressors to maintain metabolic homeostasis, contributes critically to the development of MetS/T2DM. Thus, it is essential to identify the key modifiers of phenotypic plasticity that define an individual’s susceptibility to develop T2DM. In this scenario, emerging evidence indicates that, under adve...

ea0041oc9.4 | Endocrine Tumours | ECE2016

The truncated somatostatin receptor sst5TMD4 is overexpressed in prostate cancer, where it increases aggressiveness features by regulating key tumor suppressors and oncogenes.

Hormaechea-Agulla Daniel , Manuel Jimenez-Vacas Juan , Ibanez-Costa Alejandro , Gomez-Gomez Enrique , Carrasco-Valiente Julia , Valero Rosa Jose , Moreno Maria M , Culler Michael D , Gahete Manuel D , Jose Requena Maria , Castano Justo P , Luque Raul M

Somatostatin is a pleiotropic neuropeptide that governs multiple biological targets, including tumor cell function, through a family of G protein-coupled receptors with 7-transmembrane domains (TMD), named sst1-5. However, we recently discovered sst5TMD4, an aberrantly spliced, truncated (only 4-TMDs) sst5-variant displaying unique molecular/functional features. sst5TM4 is overexpressed in various endocrine-related tumors exacerbating their malignant characteristics. Here, we ...

ea0041gp131 | Obesity | ECE2016

The liver of obese patients with hepatic steatosis exhibits a severe dysregulation of key splicing machinery components as compared to obese patients without hepatic steatosis

Rio-Moreno Mercedes del , Pedraza-Arevalo Sergio , Gonzalez-Rubio Sandra , Ferrin Gustavo , Gahete Manuel D , Rodriguez-Peralvarez Manuel , Kineman Rhonda D , Ibanez-Costa Alejandro , de la Mata Manuel , Castano Justo P , Luque Raul M

Obesity, a disease that is growing at epidemic proportions worldwide, is caused by a combination of genetic and lifestyle factors. One of the most common pathologies associated with obesity is hepatic steatosis, an accumulation of fat within the liver that can progress to liver fibrosis, cirrhosis, and ultimately lead to hepatocellular carcinoma. There is emerging evidence that alternative mRNA splicing, the key mechanism providing transcript and protein diversity, is dysregul...

ea0035p788 | Obesity | ECE2014

Dietary fat alters the expression of cortistatin and ghrelin systems in the PBMCs of elderly subjects: Putative implications in the postprandial inflammatory response

Gahete Manuel D. , Luque Raul M. , Yubero-Serrano Elena M. , Cruz-Teno Cristina , Ibanez-Costa Alejandro , Delgado-Lista Javier , Gracia-Navarro Francisco , Perez-Jimenez Francisco , Castano Justo P. , Lopez-Miranda Jose

Dietary fat influences systemic inflammatory status, which, in turn, determines the progression of age-associated diseases. Peripheral blood mononuclear cells (PBMCs) comprise a subset of white blood cells placed at the crossroad between diet and inflammation, in that they play a key role in the immune/inflammatory system and their gene expression pattern is influenced by diet. Since the somatostatin (SST), cortistatin (CORT) and ghrelin systems have been shown to modulate the...

ea0056gp48 | Adrenal medulla and NETs | ECE2018

In vitro studies reveal a potential therapeutic role of the combination of biguanides and statins for the treatment of prostate cancer

Herrero-Aguayo Vicente , Jimenez-Vacas Juan M , Gomez-Gomez Enrique , Leon-Gonzalez Antonio J , Saez-Martinez Prudencio , Requena-Tapia Maria J , Gahete Manuel D , Castano Justo P , Luque Raul M

Prostate cancer (PCa) is the most common tumor pathology in men worldwide. The medical treatments currently used as first-line therapy after surgery are anti-androgens like abiraterone or enzalutamide, which, unfortunately, fail to stop the disease in a high percentage of cases, resulting in progression towards aggressive castration-resistant PCa. Therefore, new therapeutic tools to manage PCa are urgently needed. Biguanides and statins, two types of drugs commonly used in met...

ea0056gp196 | Pituitary Basic | ECE2018

E-cadherin expression is associated with the response to somatostatin analogues in patients with acromegaly

Cano David A , Venegas-Moreno Eva , Gros-Herguido Noelia , Dios Elena , Flores-Martinez Alvaro , Gonzalez Natividad , Madrazo-Atutxa Ainara , Cardenas Eugenio , Kaen Ariel , Castano Justo P , Luque Raul M , Soto-Moreno Alfonso

Aim: To assess whether E-cadherin expression levels in somatotropinomas were associated with the response to somatostatin analogues (SSAs) therapy in patients with acromegaly.Methods: In this retrospective study, 56 acromegaly patients that underwent transsphenoidal surgery were evaluated. All patients were treated preoperatively with SSAs (octreotide or lanreotide) for at least 6 months. Responsiveness to SSAs was evaluated by percent IGF-1 reduction af...

ea0056gp199 | Pituitary Basic | ECE2018

Prominent expression of MAX and MEG3, despite lack of mutations in MAX, suggest a potential role for 14q genes in pituitary adenomas

Ibanez-Costa Alejandro , Leton Rocio , Rivero-Cortes Esther , Alvarez-Escola Cristina , Poyo-Guerrero Paloma Rodriguez , Gavilan-Villarejo Inmaculada , Korbonits Marta , Marazuela Monica , Galvez-Moreno Maria Angeles , Soto-Moreno Alfonso , Robledo Mercedes , Castano Justo P , Luque Raul M

Pituitary adenomas (PA), as well as pheochromocytomas and paragangliomas, are neuroendocrine tumors that arise from cells derived from the pituitary, adrenal and extra-adrenal nervous system, respectively. Recent studies have identified a growing series of susceptibility genes for these pathologies. Some genes may be associated with the development of both types of pathologies, as it is the case for succinate dehydrogenase complex genes, while, PAs have not been reported to da...